Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Outros Autores: | , , |
Tipo de documento: | Relatório |
Idioma: | eng |
Título da fonte: | Arquivos brasileiros de oftalmologia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000400013 |
Resumo: | In the recent years, anti-angiogenic medications have successfully treated other diseases associated with choroidal neovascularization. The anti-angiogenic therapy alone or combined with LASER and/or steroids has been effective in controlling ocular neovascularization, not only restricted to the treatment of typical membranes due to macular degeneration in the wet form. The discovery and subsequent use of these drugs has revolutionized medicine and ophthalmology. This report illustrates an example of successful treatment in a challenging pathology where it was found important visual and anatomical response after the use of ranibizumab. |
id |
CBO-2_379b5c28c14024a10c31b9b73fe6c561 |
---|---|
oai_identifier_str |
oai:scielo:S0004-27492011000400013 |
network_acronym_str |
CBO-2 |
network_name_str |
Arquivos brasileiros de oftalmologia (Online) |
repository_id_str |
|
spelling |
Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case reportFovea centralisLuteinRetinal pigmentsTomography, optical coherenceMacula luteaMacular degenerationFluorescein angiographyChoroidal neovascularizationAntibodies, monoclonal/therapeutic useIntravitreal injectionsIn the recent years, anti-angiogenic medications have successfully treated other diseases associated with choroidal neovascularization. The anti-angiogenic therapy alone or combined with LASER and/or steroids has been effective in controlling ocular neovascularization, not only restricted to the treatment of typical membranes due to macular degeneration in the wet form. The discovery and subsequent use of these drugs has revolutionized medicine and ophthalmology. This report illustrates an example of successful treatment in a challenging pathology where it was found important visual and anatomical response after the use of ranibizumab.Conselho Brasileiro de Oftalmologia2011-08-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000400013Arquivos Brasileiros de Oftalmologia v.74 n.4 2011reponame:Arquivos brasileiros de oftalmologia (Online)instname:Conselho Brasileiro de Oftalmologia (CBO)instacron:CBO10.1590/S0004-27492011000400013info:eu-repo/semantics/openAccessVentura,Alexandre Augusto Cabral de MelloGrant,Lorna WinifredDadgostar,HajirLewis,Hileleng2011-11-04T00:00:00Zoai:scielo:S0004-27492011000400013Revistahttp://aboonline.org.br/https://old.scielo.br/oai/scielo-oai.phpaboonline@cbo.com.br||abo@cbo.com.br1678-29250004-2749opendoar:2011-11-04T00:00Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO)false |
dc.title.none.fl_str_mv |
Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report |
title |
Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report |
spellingShingle |
Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report Ventura,Alexandre Augusto Cabral de Mello Fovea centralis Lutein Retinal pigments Tomography, optical coherence Macula lutea Macular degeneration Fluorescein angiography Choroidal neovascularization Antibodies, monoclonal/therapeutic use Intravitreal injections |
title_short |
Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report |
title_full |
Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report |
title_fullStr |
Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report |
title_full_unstemmed |
Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report |
title_sort |
Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report |
author |
Ventura,Alexandre Augusto Cabral de Mello |
author_facet |
Ventura,Alexandre Augusto Cabral de Mello Grant,Lorna Winifred Dadgostar,Hajir Lewis,Hilel |
author_role |
author |
author2 |
Grant,Lorna Winifred Dadgostar,Hajir Lewis,Hilel |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Ventura,Alexandre Augusto Cabral de Mello Grant,Lorna Winifred Dadgostar,Hajir Lewis,Hilel |
dc.subject.por.fl_str_mv |
Fovea centralis Lutein Retinal pigments Tomography, optical coherence Macula lutea Macular degeneration Fluorescein angiography Choroidal neovascularization Antibodies, monoclonal/therapeutic use Intravitreal injections |
topic |
Fovea centralis Lutein Retinal pigments Tomography, optical coherence Macula lutea Macular degeneration Fluorescein angiography Choroidal neovascularization Antibodies, monoclonal/therapeutic use Intravitreal injections |
description |
In the recent years, anti-angiogenic medications have successfully treated other diseases associated with choroidal neovascularization. The anti-angiogenic therapy alone or combined with LASER and/or steroids has been effective in controlling ocular neovascularization, not only restricted to the treatment of typical membranes due to macular degeneration in the wet form. The discovery and subsequent use of these drugs has revolutionized medicine and ophthalmology. This report illustrates an example of successful treatment in a challenging pathology where it was found important visual and anatomical response after the use of ranibizumab. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-08-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/report |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
report |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000400013 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000400013 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0004-27492011000400013 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Conselho Brasileiro de Oftalmologia |
publisher.none.fl_str_mv |
Conselho Brasileiro de Oftalmologia |
dc.source.none.fl_str_mv |
Arquivos Brasileiros de Oftalmologia v.74 n.4 2011 reponame:Arquivos brasileiros de oftalmologia (Online) instname:Conselho Brasileiro de Oftalmologia (CBO) instacron:CBO |
instname_str |
Conselho Brasileiro de Oftalmologia (CBO) |
instacron_str |
CBO |
institution |
CBO |
reponame_str |
Arquivos brasileiros de oftalmologia (Online) |
collection |
Arquivos brasileiros de oftalmologia (Online) |
repository.name.fl_str_mv |
Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO) |
repository.mail.fl_str_mv |
aboonline@cbo.com.br||abo@cbo.com.br |
_version_ |
1754209026880569344 |